Am J Psychiatry 160:1580-1586, September 2003
© 2003 American Psychiatric Association
The Schizophrenia Phenotype in 22q11 Deletion Syndrome
Anne S. Bassett, M.D., F.R.C.P.C.,
Eva W.C. Chow, M.D., F.R.C.P.C.,
Philip AbdelMalik, B.Sc.,
Mirona Gheorghiu, B.A.,
Janice Husted, Ph.D., and
Rosanna Weksberg, Ph.D., M.D., F.R.C.P.C.
OBJECTIVE: This study investigated the schizophrenia phenotype in 24 subjects with 22q11 deletion syndrome (22qDS) and schizophrenia (22qDS-schizophrenia), a rare but relatively homogenous genetic subtype of schizophrenia associated with a microdeletion on chromosome 22. Individuals with 22qDS are at genetically high risk for schizophrenia. METHOD: Standard measures of signs, symptoms, and course of schizophrenia were assessed in 16 adults with 22qDS-schizophrenia who did not meet criteria for mental retardation and in 46 adults with schizophrenia without evidence of 22qDS from a community familial sample. RESULTS: There were no significant differences in age at onset, lifetime or cross-sectional core positive and negative schizophrenic symptoms, or global functioning between the two groups of patients with schizophrenia. Patients with 22qDS-schizophrenia had higher excitement subscale scores and less lifetime substance use than the comparison patients with schizophrenia, but no significant differences in anxiety-depression symptom severity were found between the groups. CONCLUSIONS: These findings indicate that the core clinical schizophrenia phenotype would not distinguish individuals with a 22qDS subtype from those with schizophrenia who did not have the 22qDS subtype. The results provide further support for the utility of 22qDS-schizophrenia as a neurodevelopmental model of schizophrenia as well as support for prospective studies of individuals with 22qDS to help identify precursors of schizophrenia.
This article has been cited by other articles:
|
|
|
|
 
T.R. Kiehl, E.W.C. Chow, D.J. Mikulis, S.R. George, and A.S. Bassett
Neuropathologic Features in Adults with 22q11.2 Deletion Syndrome
Cereb Cortex,
May 21, 2008;
(2008)
bhn066v2.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Gothelf, C. Feinstein, T. Thompson, E. Gu, L. Penniman, E. Van Stone, H. Kwon, S. Eliez, and A. L. Reiss
Risk Factors for the Emergence of Psychotic Disorders in Adolescents With 22q11.2 Deletion Syndrome
Am J Psychiatry,
April 1, 2007;
164(4):
663 - 669.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Raux, E. Bumsel, B. Hecketsweiler, T. van Amelsvoort, J. Zinkstok, S. Manouvrier-Hanu, C. Fantini, G.-M. M. Breviere, G. Di Rosa, G. Pustorino, et al.
Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome
Hum. Mol. Genet.,
January 1, 2007;
16(1):
83 - 91.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Paylor, B. Glaser, A. Mupo, P. Ataliotis, C. Spencer, A. Sobotka, C. Sparks, C.-H. Choi, J. Oghalai, S. Curran, et al.
Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome
PNAS,
May 16, 2006;
103(20):
7729 - 7734.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Harris
22q11 Deletion Syndrome and Forensic Research: Can We Go There?
J Am Acad Psychiatry Law,
March 1, 2005;
33(1):
106 - 111.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. D. BAKER and D. H. SKUSE
Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group
The British Journal of Psychiatry,
February 1, 2005;
186(2):
115 - 120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Look at Schizophrenia in Patients with 22q11 Deletion Syndrome
Journal Watch Psychiatry,
November 5, 2003;
2003(1105):
7 - 7.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2003
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
